
Monday, October 30, 2023 4:30:55 PM
https://www.alphatau.com/single-post/atm-enters-into-long-term-lease-of-site-in-new-hampshire-for-second-u-s-manufacturing-facility
The Hudson site promises to be larger than our existing Lawrence site, and is expected to support our goals of materially scaling up capacity as well as achieving manufacturing redundancy
Recent DRTS News
- Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/12/2025 08:02:00 PM
- Alpha Tau to Participate in March Investor Conferences • GlobeNewswire Inc. • 02/27/2025 02:00:00 PM
- Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification • GlobeNewswire Inc. • 02/24/2025 01:30:00 PM
- Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease • GlobeNewswire Inc. • 02/03/2025 01:30:00 PM
- Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day • GlobeNewswire Inc. • 01/27/2025 02:00:00 PM
- Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day • GlobeNewswire Inc. • 12/18/2024 01:30:00 PM
- Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor • GlobeNewswire Inc. • 12/17/2024 02:00:00 PM
- Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/11/2024 01:30:00 PM
- Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium • GlobeNewswire Inc. • 12/06/2024 01:30:00 PM
- Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/19/2024 09:00:00 PM
- Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/13/2024 01:30:00 PM
- Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme • GlobeNewswire Inc. • 10/21/2024 12:30:24 PM
- Alpha Tau Treats First Patient with Recurrent Lung Cancer • GlobeNewswire Inc. • 10/10/2024 12:30:00 PM
- Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC • GlobeNewswire Inc. • 09/20/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/22/2024 12:32:25 PM
- Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Con • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2024 08:10:17 PM
- Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2024 08:02:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2024 08:01:44 PM
- Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers • GlobeNewswire Inc. • 06/25/2024 12:30:00 PM
- Alpha Tau to Present at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/21/2024 12:45:00 PM
- Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/20/2024 08:01:00 PM
- Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer • GlobeNewswire Inc. • 05/13/2024 12:30:00 PM
- Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow • GlobeNewswire Inc. • 05/06/2024 12:30:00 PM
- Alpha Tau to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making • SIGY • Mar 12, 2025 9:41 AM